Famotidine

Famotidine is used to treat duodenal ulcer, dyspepsia, peptic esophagitis, gastroesophageal reflux, heartburn and helicobacter infections, per the National Library of Medicine's MED-RT classification. The brand product was first FDA-approved on Oct 15, 1986, and the first generic was approved Apr 16, 2001. FDA's Orange Book lists 52 AB-rated (therapeutically equivalent) products for this ingredient. In 2024, Medicare Part D spent $180 million on Famotidine across 14.0 million claims for 3.9 million beneficiaries.

Famotidine is available as 135 NDCs from 39 manufacturers (135 generic, 0 brand), with NADAC prices from $0.03 to $0.15 per EA — the most expensive product costs about 5.1× the cheapest. Every pack size and labeler in this drug market is compared side-by-side below.